Back to Search
MARK BRUNVAND, MD
MD
Hematology & Oncology Physician
NPI: 1891779534Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
26243(CO)
Research & Publications (4)
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
PMID 17244684·Blood·2007
2-rct
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
PMID 15120931·Leuk Res·2004
3-trial
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
PMID 12916869·Leuk Lymphoma·2003
3-trial
Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells.
PMID 11781715·Genes Immun·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1721 E 19TH AVE, STE 200-300
DENVER, CO 80218 - Phone
- (720) 754-4800
Quick Facts
- NPI
- 1891779534
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 4
Are you this provider?
Claim Your Profile